Traditional Chinese medicine by shandong science

and technology progress prize four achievements

     China TianHongShun TCM quote dispatch (reporter) May 26, shandong province people's government promulgated in shandong science and technology about the 2010 annual awards to promote the decision, science and technology progress, economic and social development made outstanding contributions shall give awards to units and individuals of four Chinese medicine scientific research achievements, has won the award. Among them, shandong DongA donkey-hide gelatine Co., LTD and east China university of science and technology of recombinant human completed jointly organised fibrinolytic enzyme development and industrialization original kinase derivatives project, heze step length pharmaceutical Co., LTD. Completed Dan red injection research and development projects, scientific and technological progress award by shandong province; Shandong holy flourishing pharmaceutical Co., LTD. And shandong university of traditional Chinese medicine do together sweet chrysanthemum sugar industry key common technology and industrialization of recycle economy mode program by research and its application in shandong science and technology progress prize; Yantai university and shandong targets drug research Co., ltd., jointly completed from the antitumor innovation to traditional Chinese medicine pharmaceutical research and development program by science and technology progress prize of shandong province.

    It is reported, obtain scientific and technological progress first prize of two projects, each characteristic and has good economic and social benefits. Recombinant human tissue fibrinolytic enzyme development and original kinase derivatives, according to the industrialization project of myocardial infarction patients acute and rescue time is short, the use of drugs etc, choose expensive developed tPA derivatives - recombinant human tissue fibrinolytic enzyme original kinase derivatives, the drug has thrombolysis role of strong, effect quickly, maintenance time is long, ZaiTongLv high, adverse reactions small, use convenient wait for a characteristic, used for acute myocardial infarction treatment of thrombosis disease, is the optimal drugs. This product for the country, obtaining the kinds of new drug certificate and the approval number, realizing the industrialization and marketed products, enter Beijing, jinan, guangzhou etc. More than 400 hospitals for patients with acute myocardial infarction, lifted ailment.

    Dan red injection is our self-developed have independent intellectual property patent medicine, currently the only allow production in shandong province, is the main tcmi used to treat blood stasis caused by 6, shut the resistance of the new type of traditional Chinese medicine. Stroke The product formula is unique, definite effect advanced technology. Listed in three short years, single species in cardiovascular field sales in China and the 2009 tcmi achieved sales revenue 10.6 million yuan.